Agner, K. Detoxicating effect of verdoperoxidase on toxins Nature 1947, 159, 271-272 10.1038/159271a0
Harrison, J. E.; Schultz, J. Studies on the chlorinating activity of myeloperoxidase J. Biol. Chem. 1976, 251, 1371-1374
Klebanoff, S. J. Myeloperoxidase: Friend and foe J. Leukocyte Biol. 2005, 77, 598-562 10.1189/jlb.1204697
Schultz, J.; Kaminker, K. Myeloperoxidase of the leukocyte of normal human blood. I. Content and localization Arch. Biochem. Biophys. 1962, 96, 465-467 10.1016/0003-9861(62)90321-1
Salmon, S. E.; Cline, M. J.; Schultz, J.; Lehrer, R. I. Myeloperoxidase deficiency. Immunologic study of a genetic leukocyte defect N. Engl. J. Med. 1970, 282, 250-253 10.1056/NEJM197001292820505
Fiedler, T. J.; Davey, C.; Fenna, R. X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution J. Biol. Chem. 2000, 275, 11964-11971 10.1074/jbc.275.16.11964
Furtmüller, P.; Burner, U.; Obinger, C. Reaction of human myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate Biochemistry 1998, 37, 17923-17930 10.1021/bi9818772
Zederbauer, M.; Furtmüller, P. G.; Brogioni, S.; Jakopitsch, C.; Smulevich, G.; Obinger, C. Heme to protein linkages in mammalian peroxidases: Impact on spectroscopic, redox and catalytic properties Nat. Prod. Rep. 2007, 24, 571-584 10.1039/B604178G
Jantschko, W.; Furtmüller, P. G.; Zederbauer, M.; Neugschwandtner, K.; Lehner, I.; Jakopitsch, C.; Arnhold, J.; Obinger, C. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design Biochem. Pharmacol. 2005, 69, 1149-1157 10.1016/j.bcp.2005.02.006
Nicholls, S.; Hazen, S. Myeloperoxidase and cardiovascular disease Arterioscler., Thromb., Vasc. Biol. 2005, 25, 1102-1111 10.1161/01.ATV.0000163262.83456.6d
Hazen, S. Myeloperoxidase and plaque vulnerability Arterioscler., Thromb., Vasc. Biol. 2004, 24, 1143-1146 10.1161/01.ATV.0000135267.82813.52
Van Antwerpen, P.; Dufrasne, F.; Lequeux, M.; Zouaoui Boudjeltia, K.; Lessgyer, I.; Babar, S.; Moreau, P.; Moguilevsky, N.; Vanhaeverbeek, M.; Ducobu, J.; Neve, J. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: Flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid Eur. J. Pharmacol. 2007, 570, 235-243 10.1016/j.ejphar.2007.05.057
Soubhye, J.; Prévost, M.; Van Antwerpen, P.; Zouaoui Boudjeltia, K.; Rousseau, A.; Furtmüller, P. G.; Obinger, C.; Vanhaeverbeek, M.; Ducobu, J.; Neve, J.; Gelbcke, M.; Dufrasne, F. Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors J. Med. Chem. 2010, 53, 8747-8759 10.1021/jm1009988
Forbes, L.; Sjögren, T.; Auchère, F.; Jenkins, D.; Thong, B.; Laughton, D.; Hemsley, P.; Pairaudeau, G.; Turner, R.; Eriksson, H.; Unitt, J.; Kettle, A. Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates J. Biol. Chem. 2013, 288, 36636-36647 10.1074/jbc.M113.507756
Roth, A.; Ott, S.; Farber, K.; Palazzo, T.; Conrad, W.; Haddadin, M.; Tantillo, D.; Cross, C.; Eiserich, J.; Kurth, M. Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones Bioorg. Med. Chem. 2014, 22, 6422-6429 10.1016/j.bmc.2014.09.044
Blair-Johnson, M.; Fiedler, T.; Fenna, R. Human myeloperoxidase: structure of a cyanide complex and its interaction with bromide and thiocyanate substrates at 1.9 A resolution Biochemistry 2001, 40, 13990-13997 10.1021/bi0111808
Tidén, A. K.; Sjögren, T.; Svensson, M.; Bernlind, A.; Senthilmohan, R.; Auchère, F.; Norman, H.; Markgren, P. O.; Gustavsson, S.; Schmidt, S.; Lundquist, S.; Forbes, L. V.; Magon, N. J.; Paton, L. N.; Jameson, G. N.; Eriksson, H.; Kettle, A. 2-Thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation J. Biol. Chem. 2011, 286, 37578-37589 10.1074/jbc.M111.266981
Davey, C.; Fenna, R. 2.3 A resolution X-ray crystal structure of the bisubstrate analogue inhibitor salicylhydroxamic acid bound to human myeloperoxidase: a model for a prereaction complex with hydrogen peroxide Biochemistry 1996, 35, 10967-10973 10.1021/bi960577m
Van Antwerpen, P.; Prévost, M.; Zouaoui-Boudjeltia, K.; Babar, S.; Legssyer, I.; Moreau, P.; Moguilevsky, N.; Vanhaeverbeek, M.; Ducobu, J.; Neve, J.; Dufrasne, F. Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification Bioorg. Med. Chem. 2008, 16, 1702-1720 10.1016/j.bmc.2007.11.025
Aldib, I.; Soubhye, J.; Zouaoui Boudjeltia, K.; Vanhaeverbeek, M.; Rousseau, A.; Furtmüller, P. G.; Obinger, C.; Dufrasne, F.; Nève, J.; Van Antwerpen, P.; Prévost, M. Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening J. Med. Chem. 2012, 55, 7208-7218 10.1021/jm3007245
Soubhye, J.; Aldib, I.; Delporte, C.; Prévost, M.; Dufrasne, F.; Van Antwerpen, P. Myeloperoxidase as a target for treatment of inflammatory syndromes: mechanisms and structure activity relationships of inhibitors Curr. Med. Chem. 2016, 23, 3975-4008 10.2174/0929867323666160607111806
Malvezzi, A.; Queiroz, R. F.; De Rezende, L.; Augusto, O.; do Amaral, A. T. MPO inhibitors selected by virtual screening Mol. Inf. 2011, 30, 605-613 10.1002/minf.201100016
Wolber, G.; Langer, T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J. Chem. Inf. Model. 2005, 45, 160-169 10.1021/ci049885e
Soubhye, J.; Alard, I. C.; van Antwerpen, P.; Dufrasne, F. Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis Future Med. Chem. 2015, 7, 1431-1456 10.4155/fmc.15.74
Vuorinen, A.; Engeli, R.; Meyer, A.; Bachmann, F.; Griesser, U.; Schuster, D.; Odermatt, A. Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase2 inhibitors J. Med. Chem. 2014, 57, 5995-6007 10.1021/jm5004914
Venugopala, K.; Govender, R.; Khedr, M.; Venugopala, R.; Aldhubiab, B.; Harsha, S.; Odhav, B. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents Drug Des., Dev. Ther. 2015, 9, 911-921 10.2147/DDDT.S73890
Irwin, J.; Shoichet, B. K. ZINC-a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 2005, 45, 177-182 10.1021/ci049714+
Soubhye, J.; Aldib, I.; Prévost, M.; Elfving, B.; Gelbcke, M.; Podrecca, M.; Conotte, R.; Colet, J.; Furtmüller, P. G.; Delporte, C.; Rousseau, A.; Vanhaeverbeek, M.; Nève, J.; Obinger, C.; Zouaoui-Boudjeltia, K.; Van Antwerpen, P.; Dufrasne, F. Hybrid molecules inhibiting myeloperoxidase activity and serotonin reuptake: a possible new approach of major depressive disorders with inflammatory syndrome J. Pharm. Pharmacol. 2014, 66, 1122-1132 10.1111/jphp.12236
Soubhye, J.; Aldib, I.; Elfving, B.; Gelbcke, M.; Furtmüller, P. G.; Podrecca, M.; Conotte, R.; Colet, J.; Rousseau, A.; Reye, F.; Sarakbi, A.; Vanhaeverbeek, M.; Kauffmann, J. M.; Obinger, C.; Nève, J.; Prévost, M.; Zouaoui-Boudjeltia, K.; Van Antwerpen, P.; Dufrasne, F. Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors J. Med. Chem. 2013, 56, 3943-3958 10.1021/jm4001538
Zeraik, M.; Ximenes, V.; Regasini, L.; Dutra, L.; Silva, D.; Fonseca, L.; Coelho, D.; Machado, S.; Bolzani, V. 4'-Aminochalcones as novel inhibitors of the chlorinating activity of myeloperoxidase Curr. Med. Chem. 2012, 19, 5405-5413 10.2174/092986712803833344
Boufadi, Y.; Soubhye, J.; Riazi, A.; Rousseau, A.; Vanhaeverbeek, M.; Nève, J.; Boudjeltia, K.; Van Antwerpen, P. Characterization and antioxidant properties of six Algerian propolis extracts: ethyl acetate extracts inhibit myeloperoxidase activity Int. J. Mol. Sci. 2014, 15, 2327-2345 10.3390/ijms15022327
Kleszczyñski, K.; Hardkop, L.; Fischer, T. Differential effects of melatonin as a broad range UV-damage preventive dermato-endocrine regulator Derm.-Endocrinol. 2011, 3, 27-31 10.4161/derm.3.1.14842
Van Antwerpen, P.; Dufrasne, F.; Lequeux, M.; Boudjeltia, K.; Lessgyer, I.; Babar, S.; Moreau, P.; Moguilevsky, N.; Vanhaeverbeek, M.; Ducobu, J.; Nève, J. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid Eur. J. Pharmacol. 2007, 570, 235-243 10.1016/j.ejphar.2007.05.057
Ruggeri, R. B.; Buckbinder, L.; Bagley, S. W.; Carpino, P. A.; Conn, E. L.; Dowling, M. S.; Fernando, D. P.; Jiao, W.; Kung, D. W.; Orr, S. T.; Qi, Y.; Rocke, B. N.; Smith, A.; Warmus, J. S.; Zhang, Y.; Bowles, D.; Widlicka, D. W.; Eng, H.; Ryder, T.; Sharma, R.; Wolford, A.; Okerberg, C.; Walters, K.; Maurer, T. S.; Zhang, Y.; Bonin, P. D.; Spath, S. N.; Xing, G.; Hepworth, D.; Ahn, K.; Kalgutkar, A. S. Discovery of 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): a highly selective mechanism-based myeloperoxidase inhibitor for the treatment of cardiovascular diseases J. Med. Chem. 2015, 58, 8513-8528 10.1021/acs.jmedchem.5b00963
Egan, R.; Hagmann, W.; Gale, P. Naphthalenes as inhibitors of myeloperoxidase: direct and indirect mechanisms of inhibition Agents Actions 1990, 29, 266-276 10.1007/BF01966457
Nève, J.; Parij, N.; Moguilevsky, N. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs investigated with a human recombinant enzyme Eur. J. Pharmacol. 2001, 417, 37-43 10.1016/S0014-2999(01)00895-0
Kettle, A.; Winterbourn, C. Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs Biochem. Pharmacol. 1991, 41, 1485-1492 10.1016/0006-2952(91)90565-M
Sinha, B. K.; Mason, R. P. Biotransformation of hydrazine derivatives in the mechanism of toxicity J. Drug Metab. Toxicol. 2014, 5, 168 10.4172/2157-7609.1000168
Webb, T.; Lvovskiy, L.; Kim, S.; Ji, X.; Melman, N.; Linden, J.; Jacobson, K. Quinazolines as adenosine receptor antagonists: SAR and selectivity for A2B receptors Bioorg. Med. Chem. 2003, 11, 77-85 10.1016/S0968-0896(02)00323-1
Cheng, F.; Li, W.; Zhou, Y.; Shen, J.; Wu, Z.; Liu, G.; Lee, P.; Tang, Y. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties J. Chem. Inf. Model. 2012, 52, 3099-3105 10.1021/ci300367a
Zámocký, M.; Hofbauer, S.; Schaffner, I.; Gasselhuber, B.; Nicolussi, A.; Soudi, M.; Pirker, K. F.; Furtmüller, P. G.; Obinger, C. Independent evolution of four heme peroxidase superfamilies Arch. Biochem. Biophys. 2015, 574, 108-119 10.1016/j.abb.2014.12.025
Sutherland, J.; Nandigam, R.; Erickson, J.; Vieth, M. Lessons in molecular recognition. 2. Assessing and improving cross-docking accuracy J. Chem. Inf. Model. 2007, 47, 2293-22302 10.1021/ci700253h
Soubhye, J.; Meyer, F.; Furtmüller, P. G.; Obinger, C.; Dufrasne, F.; van Antwerpen, P. Characterization of chemical features of potent myeloperoxidase inhibitors Future Med. Chem. 2016, 8, 1163-1177 10.4155/fmc-2016-0031
Carr, A. C.; Myzak, M. C.; Stocker, R.; McCall, M. R.; Frei, B. Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis FEBS Lett. 2000, 487, 176-180 10.1016/S0014-5793(00)02227-4
Van Antwerpen, P.; Prévost, M.; Zouaoui-Boudjeltia, K.; Babar, S.; Legssyer, I.; Moreau, P.; Moguilevsky, N.; Vanhaeverbeek, M.; Ducobu, J.; Nève, J.; Dufrasne, F. Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification Bioorg. Med. Chem. 2008, 16, 1702-1720 10.1016/j.bmc.2007.11.025
Ross-Lee, L.; Eadie, M.; Hooper, W.; Bochner, F. Single-dose pharmacokinetics of metoclopramide Eur. J. Clin. Pharmacol. 1981, 20, 465-471 10.1007/BF00542101
Shepherd, A.; McNay, J.; Ludden, M.; Lin, M.; Musgrave, G. Plasma concentration and acetylator phenotype determine response to oral hydralazine Hypertension 1981, 3, 580-585 10.1161/01.HYP.3.5.580
Soubhye, J.; Gelbcke, M.; Van Antwerpen, P.; Dufrasne, F.; Boufadi, M. Y.; Nève, J.; Furtmüller, P. G.; Obinger, C.; Zouaoui Boudjeltia, K.; Meyer, F. From dynamic combinatorial chemistry to in vivo evaluation of reversible and irreversible myeloperoxidase inhibitors ACS Med. Chem. Lett. 2017, 8, 206-210 10.1021/acsmedchemlett.6b00417
Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A fast flexible docking method using an incremental construction algorithm J. Mol. Biol. 1996, 261, 470-89 10.1006/jmbi.1996.0477
Schneider, N.; Hindle, S.; Lange, G.; Klein, R.; Albrecht, J.; Briem, H.; Beyer, K.; Claußen, H.; Gastreich, M.; Lemmen, C.; Rarey, M. Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function J. Comput.-Aided Mol. Des. 2012, 26, 701-23 10.1007/s10822-011-9531-0
Friesner, R. A.; Murphy, R. B.; Repasky, M. P.; Frye, L. L.; Greenwood, J. R.; Halgren, T. A.; Sanschagrin, P. C.; Mainz, D. T. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes J. Med. Chem. 2006, 49, 6177-6196 10.1021/jm051256o
Greenwood, J. R.; Calkins, D.; Sullivan, A. P.; Shelley, J. C. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution J. Comput.-Aided Mol. Des. 2010, 24, 591-604 10.1007/s10822-010-9349-1
Furtmüller, P. G.; Burner, U.; Obinger, C. Reaction of human myeloperoxidase Compound I with chloride, bromide, iodide, and thiocyanate Biochemistry 1998, 37, 17923-17930 10.1021/bi9818772
Hewson, W. D.; Hager, L. P. Mechanism of the chlorination reaction catalyzed by horseradish peroxidase with chlorite J. Biol. Chem. 1979, 254, 3175-3181
Havel, R. J.; Eder, H. A.; Bragdon, J. H. Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J. Clin. Invest. 1955, 34, 1345-1353 10.1172/JCI103182
Van Antwerpen, P.; Zouaoui Boudjeltia, K.; Babar, S.; Legssyer, I.; Moreau, P.; Moguilevsky, N.; Vanhaeverbeek, M.; Ducobu, J.; Nève, J. Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation Biochem. Biophys. Res. Commun. 2005, 337, 82-88 10.1016/j.bbrc.2005.09.013
Gau, J.; Furtmüller, G. P.; Obinger, C.; Prévost, M.; Van Antwerpen, P.; Arnhold, J.; Flemmig, J. Flavonoids as promoters of the (pseudo-)halogenating activity of lactoperoxidase and myeloperoxidase Free Radical Biol. Med. 2016, 97, 307-319 10.1016/j.freeradbiomed.2016.06.026
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65, 55-63 10.1016/0022-1759(83)90303-4
Flemmig, J.; Lessig, J.; Reibetanz, U.; Dautel, P.; Arnhold, J. Non-vital polymorphonuclear leukocytes express myeloperoxidase on their surface Cell. Physiol. Biochem. 2008, 21, 287-296 10.1159/000129387
Kettle, A.; Gedye, C.; Winterbourn, C. Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide Biochem. J. 1997, 321, 503-508 10.1042/bj3210503
Flemmig, J.; Remmler, J.; Rohring, F.; Arnhold, J. (-)-Epicatechin regenerates the chlorinating activity of myeloperoxidase in vitro and in neutrophil granulocytes J. Inorg. Biochem. 2014, 130, 84-91 10.1016/j.jinorgbio.2013.10.002
Flemmig, J.; Remmler, J.; Zschaler, J.; Arnhold, J. Detection of the halogenating activity of heme peroxidases in leukocytes by aminophenyl fluorescein Free Radical Res. 2015, 49, 768-776 10.3109/10715762.2014.999676
Beers, R. J., Jr.; Sizer, I. W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase J. Biol. Chem. 1952, 195, 133-140
